The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 19387355)

Published in J Acquir Immune Defic Syndr on August 01, 2009

Authors

Jisoo A Kwon1, Jenny Iversen, Lisa Maher, Matthew G Law, David P Wilson

Author Affiliations

1: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, New South Wales, Australia.

Articles citing this

Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet (2010) 2.26

Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis (2013) 1.19

Translation of biomedical prevention strategies for HIV: prospects and pitfalls. J Acquir Immune Defic Syndr (2013) 1.12

Needle and syringe programs in Yunnan, China yield health and financial return. BMC Public Health (2011) 1.05

Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity. J Infect Dis (2011) 0.95

Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012. PLoS One (2014) 0.91

Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine (2010) 0.91

The HIV Epidemic: High-Income Countries. Cold Spring Harb Perspect Med (2012) 0.90

Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains. AIDS Res Hum Retroviruses (2014) 0.86

Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1. Viruses (2012) 0.82

Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China. Harm Reduct J (2013) 0.80

Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call. J AIDS Clin Res (2013) 0.79

Beyond equipment distribution in Needle and Syringe Programmes: an exploratory analysis of blood-borne virus risk and other measures of client need. Harm Reduct J (2016) 0.79

HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis. BMC Public Health (2016) 0.75

A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations. Harm Reduct J (2015) 0.75

Articles by these authors

Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med (2007) 12.93

Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23

Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy. AIDS (2009) 10.84

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21

Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet (2006) 4.45

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care (2008) 4.10

Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics. Drug Alcohol Rev (2005) 4.02

The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr (2005) 3.18

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14

Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis (2009) 2.89

HIV prevalence in China: integration of surveillance data and a systematic review. Lancet Infect Dis (2013) 2.82

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil (2010) 2.70

Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS (2010) 2.65

Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS (2005) 2.33

A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia. Clin Infect Dis (2014) 2.20

Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade. Hypertension (2009) 2.20

Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog (2011) 2.13

Type III secretion à la Chlamydia. Trends Microbiol (2007) 2.08

HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis (2011) 2.08

Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis (2008) 2.06

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation (2009) 2.01

Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis (2012) 2.01

Heteromultimeric TRPC6-TRPC7 channels contribute to arginine vasopressin-induced cation current of A7r5 vascular smooth muscle cells. Circ Res (2006) 1.99

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98

The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol (2003) 1.78

Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis (2011) 1.74

Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health (2009) 1.70

Human immunodeficiency virus prevalence is increasing among men who have sex with men in China: findings from a review and meta-analysis. Sex Transm Dis (2011) 1.62

Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis. AIDS (2014) 1.59

Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J (2002) 1.59

'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction (2013) 1.56

Sampling and sensitivity analyses tools (SaSAT) for computational modelling. Theor Biol Med Model (2008) 1.53

The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction (2010) 1.51

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS (2007) 1.49

Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol (2006) 1.45

What is the potential for bisexual men in China to act as a bridge of HIV transmission to the female population? Behavioural evidence from a systematic review and meta-analysis. BMC Infect Dis (2011) 1.43

HIV and syphilis co-infection increasing among men who have sex with men in China: a systematic review and meta-analysis. PLoS One (2011) 1.43

Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust (2003) 1.41

Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol (2012) 1.39

The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep (2003) 1.37

Suicide risk among recently released prisoners in New South Wales, Australia. Med J Aust (2007) 1.28

HIV and sexually transmissible infections among money boys in China: a data synthesis and meta-analysis. PLoS One (2012) 1.28

Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization. J Acquir Immune Defic Syndr (2015) 1.27

HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis (2012) 1.25

Patterns of condom use among men who have sex with men in China: a systematic review and meta-analysis. AIDS Behav (2012) 1.24

Trends in notifiable infectious diseases in China: implications for surveillance and population health policy. PLoS One (2012) 1.24

An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int (2008) 1.23

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS (2010) 1.23

Using population attributable risk to choose HIV prevention strategies in men who have sex with men. BMC Public Health (2011) 1.22

Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend (2011) 1.21

Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis (2013) 1.19

Frequent testing of highly sexually active gay men is required to control syphilis. Sex Transm Dis (2010) 1.19

The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis. PLoS One (2010) 1.19

How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18

Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open (2013) 1.18

Factors associated with mortality in a cohort of Australian prisoners. Eur J Epidemiol (2007) 1.18

Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family. Infect Immun (2009) 1.18

AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS (2009) 1.17

Would gay men change their sexual behavior to reduce syphilis rates? Sex Transm Dis (2011) 1.16

High HIV prevalence and risk of infection among rural-to-urban migrants in various migration stages in China: a systematic review and meta-analysis. Sex Transm Dis (2013) 1.16

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr (2009) 1.16

Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther (2005) 1.14

Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy. PLoS One (2012) 1.14

Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis (2012) 1.13

Understanding the mechanisms and limitations of immune control of HIV. Immunol Rev (2007) 1.13

Will changes in gay men's sexual behavior reduce syphilis rates? Sex Transm Dis (2011) 1.12

Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS (2012) 1.11

Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis (2009) 1.11

Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning. Addiction (2009) 1.10

Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood. PLoS Pathog (2008) 1.10

Injection drug users' involvement in drug dealing in the downtown eastside of Vancouver: social organization and systemic violence. Int J Drug Policy (2013) 1.09

Letter to the editor re: in vivo whole animal body imaging reveals colonization of Chlamydia muridarum to the lower genital tract at early stages of infection. Mol Imaging Biol (2014) 1.09

Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend (2007) 1.08

Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. AIDS (2011) 1.08

Risk factors and causes of death in the Australian HIV Observational Database. Sex Health (2006) 1.07

Pattern of HIV testing and multiple sexual partnerships among men who have sex with men in China. BMC Infect Dis (2013) 1.07

Needle and syringe programs in Yunnan, China yield health and financial return. BMC Public Health (2011) 1.05

Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis. PLoS One (2013) 1.05

The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care (2012) 1.05

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.05

Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison. PLoS One (2013) 1.04

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. J Int AIDS Soc (2012) 1.03

Increased HIV testing will modestly reduce HIV incidence among gay men in NSW and would be acceptable if HIV testing becomes convenient. PLoS One (2013) 1.02

Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistence. BMC Microbiol (2008) 1.00

Modeling trends in HIV incidence among homosexual men in Australia 1995-2006. J Acquir Immune Defic Syndr (2004) 1.00

HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med (2012) 0.99

A prospective study of hepatitis C incidence in Australian prisoners. Addiction (2014) 0.99

Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. Drug Alcohol Depend (2012) 0.98

Extending drug ethno-epidemiology using agent-based modelling. Addiction (2009) 0.98

Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infect Dis (2010) 0.97

Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr (2008) 0.97

Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health (2008) 0.97

Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China. Sex Health (2012) 0.97